Novel Selenium Carrier Protein Regulates Ferroptosis in Cancer and Brain🧫
👉Read more:
t1p.de/kr969
Scientists at
#HelmholtzMunich have uncovered the selenium carrier protein PRDX6 as a critical player in
#ferroptosis - a cell death process that holds promise for
#cancer and neurodegenerative disease
#therapies.
💡This study reveals PRDX6’s dual role as both a regulator of
#OxidativeStress and a selenium transporter, essential for maintaining cellular defenses against damage.
🌟Implications: Targeting PRDX6 may increase sensitivity to ferroptosis in cancer cells, a potential new strategy against therapy-resistant
#tumors. In neurodegenerative diseases like
#Alzheimer’s, PRDX6 could help protect neurons by supporting selenoprotein production, opening doors for therapeutic advancements.
@Conrad_Lab @Ferroptosis2306 @Ferroptosis1
#CancerResearch #NeurodegenerativeDisease #Selenium #MultipleSclerosis